Literature DB >> 16199517

Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles.

Aravind Subramanian1, Pablo Tamayo, Vamsi K Mootha, Sayan Mukherjee, Benjamin L Ebert, Michael A Gillette, Amanda Paulovich, Scott L Pomeroy, Todd R Golub, Eric S Lander, Jill P Mesirov.   

Abstract

Although genomewide RNA expression analysis has become a routine tool in biomedical research, extracting biological insight from such information remains a major challenge. Here, we describe a powerful analytical method called Gene Set Enrichment Analysis (GSEA) for interpreting gene expression data. The method derives its power by focusing on gene sets, that is, groups of genes that share common biological function, chromosomal location, or regulation. We demonstrate how GSEA yields insights into several cancer-related data sets, including leukemia and lung cancer. Notably, where single-gene analysis finds little similarity between two independent studies of patient survival in lung cancer, GSEA reveals many biological pathways in common. The GSEA method is embodied in a freely available software package, together with an initial database of 1,325 biologically defined gene sets.

Entities:  

Mesh:

Year:  2005        PMID: 16199517      PMCID: PMC1239896          DOI: 10.1073/pnas.0506580102

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  33 in total

1.  Identifying differentially expressed genes using false discovery rate controlling procedures.

Authors:  Anat Reiner; Daniel Yekutieli; Yoav Benjamini
Journal:  Bioinformatics       Date:  2003-02-12       Impact factor: 6.937

Review 2.  Xist RNA and the mechanism of X chromosome inactivation.

Authors:  Kathrin Plath; Susanna Mlynarczyk-Evans; Dmitri A Nusinow; Barbara Panning
Journal:  Annu Rev Genet       Date:  2002-06-11       Impact factor: 16.830

3.  MLL translocations specify a distinct gene expression profile that distinguishes a unique leukemia.

Authors:  Scott A Armstrong; Jane E Staunton; Lewis B Silverman; Rob Pieters; Monique L den Boer; Mark D Minden; Stephen E Sallan; Eric S Lander; Todd R Golub; Stanley J Korsmeyer
Journal:  Nat Genet       Date:  2001-12-03       Impact factor: 38.330

4.  Systematic discovery of regulatory motifs in human promoters and 3' UTRs by comparison of several mammals.

Authors:  Xiaohui Xie; Jun Lu; E J Kulbokas; Todd R Golub; Vamsi Mootha; Kerstin Lindblad-Toh; Eric S Lander; Manolis Kellis
Journal:  Nature       Date:  2005-02-27       Impact factor: 49.962

5.  Cloning and characterization of the common fragile site FRA6F harboring a replicative senescence gene and frequently deleted in human tumors.

Authors:  Cristina Morelli; Efthimia Karayianni; Chiara Magnanini; Andrew J Mungall; Erik Thorland; Massimo Negrini; David I Smith; Giuseppe Barbanti-Brodano
Journal:  Oncogene       Date:  2002-10-17       Impact factor: 9.867

6.  A novel gene, MSI2, encoding a putative RNA-binding protein is recurrently rearranged at disease progression of chronic myeloid leukemia and forms a fusion gene with HOXA9 as a result of the cryptic t(7;17)(p15;q23).

Authors:  Aikaterini Barbouti; Mattias Höglund; Bertil Johansson; Carin Lassen; Per-Gunnar Nilsson; Anne Hagemeijer; Felix Mitelman; Thoas Fioretos
Journal:  Cancer Res       Date:  2003-03-15       Impact factor: 12.701

Review 7.  A role for hypoxia and hypoxia-inducible transcription factors in tumor physiology.

Authors:  Till Acker; Karl H Plate
Journal:  J Mol Med (Berl)       Date:  2002-06-21       Impact factor: 4.599

8.  The immunosuppressant rapamycin mimics a starvation-like signal distinct from amino acid and glucose deprivation.

Authors:  Tao Peng; Todd R Golub; David M Sabatini
Journal:  Mol Cell Biol       Date:  2002-08       Impact factor: 4.272

9.  Gene-expression profiles predict survival of patients with lung adenocarcinoma.

Authors:  David G Beer; Sharon L R Kardia; Chiang-Ching Huang; Thomas J Giordano; Albert M Levin; David E Misek; Lin Lin; Guoan Chen; Tarek G Gharib; Dafydd G Thomas; Michelle L Lizyness; Rork Kuick; Satoru Hayasaka; Jeremy M G Taylor; Mark D Iannettoni; Mark B Orringer; Samir Hanash
Journal:  Nat Med       Date:  2002-07-15       Impact factor: 53.440

10.  MAPPFinder: using Gene Ontology and GenMAPP to create a global gene-expression profile from microarray data.

Authors:  Scott W Doniger; Nathan Salomonis; Kam D Dahlquist; Karen Vranizan; Steven C Lawlor; Bruce R Conklin
Journal:  Genome Biol       Date:  2003-01-06       Impact factor: 13.583

View more
  2000 in total

1.  An exploratory genome-wide analysis of genetic risk for alcoholic hepatitis.

Authors:  James J Beaudoin; Nanye Long; Suthat Liangpunsakul; Puneet Puri; Patrick S Kamath; Vijay Shah; Arun J Sanyal; David W Crabb; Naga P Chalasani; Thomas J Urban
Journal:  Scand J Gastroenterol       Date:  2017-08-04       Impact factor: 2.423

2.  Mitochondrial Oxidative Damage Underlies Regulatory T Cell Defects in Autoimmunity.

Authors:  Themis Alissafi; Lydia Kalafati; Maria Lazari; Anastasia Filia; Ismini Kloukina; Maria Manifava; Jong-Hyung Lim; Vasileia Ismini Alexaki; Nicholas T Ktistakis; Triantafyllos Doskas; George A Garinis; Triantafyllos Chavakis; Dimitrios T Boumpas; Panayotis Verginis
Journal:  Cell Metab       Date:  2020-07-31       Impact factor: 27.287

3.  IL-15 Preconditioning Augments CAR T Cell Responses to Checkpoint Blockade for Improved Treatment of Solid Tumors.

Authors:  Lauren Giuffrida; Kevin Sek; Melissa A Henderson; Imran G House; Junyun Lai; Amanda X Y Chen; Kirsten L Todd; Emma V Petley; Sherly Mardiana; Izabela Todorovski; Emily Gruber; Madison J Kelly; Benjamin J Solomon; Stephin J Vervoort; Ricky W Johnstone; Ian A Parish; Paul J Neeson; Lev M Kats; Phillip K Darcy; Paul A Beavis
Journal:  Mol Ther       Date:  2020-07-21       Impact factor: 11.454

4.  PRECISION MEDICINE: FROM DIPLOTYPES TO DISPARITIES TOWARDS IMPROVED HEALTH AND THERAPIES.

Authors:  Dana C Crawford; Alexander A Morgan; Joshua C Denny; Bruce J Aronow; Steven E Brenner
Journal:  Pac Symp Biocomput       Date:  2018

5.  Early pridopidine treatment improves behavioral and transcriptional deficits in YAC128 Huntington disease mice.

Authors:  Marta Garcia-Miralles; Michal Geva; Jing Ying Tan; Nur Amirah Binte Mohammad Yusof; Yoonjeong Cha; Rebecca Kusko; Liang Juin Tan; Xiaohong Xu; Iris Grossman; Aric Orbach; Michael R Hayden; Mahmoud A Pouladi
Journal:  JCI Insight       Date:  2017-12-07

6.  GeneDive: A gene interaction search and visualization tool to facilitate precision medicine.

Authors:  Paul Previde; Brook Thomas; Mike Wong; Emily K Mallory; Dragutin Petkovic; Russ B Altman; Anagha Kulkarni
Journal:  Pac Symp Biocomput       Date:  2018

7.  Accelerating permutation testing in voxel-wise analysis through subspace tracking: A new plugin for SnPM.

Authors:  Felipe Gutierrez-Barragan; Vamsi K Ithapu; Chris Hinrichs; Camille Maumet; Sterling C Johnson; Thomas E Nichols; Vikas Singh
Journal:  Neuroimage       Date:  2017-07-15       Impact factor: 6.556

8.  Hypoxia-Sensitive COMMD1 Integrates Signaling and Cellular Metabolism in Human Macrophages and Suppresses Osteoclastogenesis.

Authors:  Koichi Murata; Celestia Fang; Chikashi Terao; Eugenia G Giannopoulou; Ye Ji Lee; Min Joon Lee; Se-Hwan Mun; Seyeon Bae; Yu Qiao; Ruoxi Yuan; Moritoshi Furu; Hiromu Ito; Koichiro Ohmura; Shuichi Matsuda; Tsuneyo Mimori; Fumihiko Matsuda; Kyung-Hyun Park-Min; Lionel B Ivashkiv
Journal:  Immunity       Date:  2017-07-18       Impact factor: 31.745

9.  Increasing the level of peroxisome proliferator-activated receptor γ coactivator-1α in podocytes results in collapsing glomerulopathy.

Authors:  Szu-Yuan Li; Jihwan Park; Chengxiang Qiu; Seung Hyeok Han; Matthew B Palmer; Zoltan Arany; Katalin Susztak
Journal:  JCI Insight       Date:  2017-07-20

10.  EWS/FLI is a Master Regulator of Metabolic Reprogramming in Ewing Sarcoma.

Authors:  Jason M Tanner; Claire Bensard; Peng Wei; Nathan M Krah; John C Schell; Jamie Gardiner; Joshua Schiffman; Stephen L Lessnick; Jared Rutter
Journal:  Mol Cancer Res       Date:  2017-07-18       Impact factor: 5.852

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.